• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

13至17岁青少年对推荐的人乳头瘤病毒(HPV)疫苗接种程序的依从性:2019 - 2020年全国青少年免疫调查结果

Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019-2020.

作者信息

Ejezie Chinenye Lynette, Osaghae Ikponmwosa, Ayieko Sylvia, Cuccaro Paula

机构信息

Department of Health Promotion and Behavioral Sciences, The University of Texas School of Public Health, 1200 Pressler St, Houston, TX 77030, USA.

Department of Investigational Cancer Therapeutics, The University of MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Vaccines (Basel). 2022 Apr 8;10(4):577. doi: 10.3390/vaccines10040577.

DOI:10.3390/vaccines10040577
PMID:35455325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9026751/
Abstract

The 9-valent human papillomavirus (9-vHPV) vaccine uptake rate among adolescents has improved over the years; however, little is known about the adherence to the recommended dosing schedule. This study examines the prevalence and factors associated with adherence to the recommended 9vHPV vaccination dosing schedule among adolescents aged 13 to 17 years. The cross-sectional study was conducted using the 2019-2020 National Immunization Survey-Teen. The parents of 34,619 adolescents were included in our analyses. The overall up-to-date (UTD) prevalence was 57.1%. The UTD prevalence was 60.0% among females and 54.2% among males. Adolescents aged 16 years had the highest UTD prevalence of 63.0%. The UTD prevalence was 61.6% among Hispanics and 54.7% among non-Hispanic Whites. Overall, compared to females, males had 14% lower odds of UTD. The odds of UTD were 1.91 times, 2.08 times, and 1.98 times higher among adolescents aged 15-17 years, respectively, compared to those aged 13 years. Moreover, region, poverty, insurance status, mothers' educational level, and provider recommendation were associated with UTD. Our findings show that adherence to the recommended 9vHPV vaccine schedule is low in the US. Targeted public health efforts are needed to improve the rates of adherence to the recommended 9vHPV dose schedule.

摘要

多年来,青少年中九价人乳头瘤病毒(9-vHPV)疫苗的接种率有所提高;然而,对于是否遵循推荐的接种程序却知之甚少。本研究调查了13至17岁青少年中遵循推荐的9vHPV疫苗接种程序的流行情况及相关因素。这项横断面研究使用了2019 - 2020年全国青少年免疫调查。我们的分析纳入了34,619名青少年的父母。总体最新接种率为57.1%。女性的最新接种率为60.0%,男性为54.2%。16岁青少年的最新接种率最高,为63.0%。西班牙裔的最新接种率为61.6%,非西班牙裔白人则为54.7%。总体而言,与女性相比,男性的最新接种几率低14%。与13岁的青少年相比,15 - 17岁的青少年最新接种几率分别高出1.91倍、2.08倍和1.98倍。此外,地区、贫困状况、保险状况、母亲的教育水平以及医疗服务提供者的建议都与最新接种情况有关。我们的研究结果表明,美国遵循推荐的9vHPV疫苗接种程序的情况较差。需要有针对性地开展公共卫生工作,以提高遵循推荐的9vHPV疫苗接种程序的比例。

相似文献

1
Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019-2020.13至17岁青少年对推荐的人乳头瘤病毒(HPV)疫苗接种程序的依从性:2019 - 2020年全国青少年免疫调查结果
Vaccines (Basel). 2022 Apr 8;10(4):577. doi: 10.3390/vaccines10040577.
2
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.2019 年美国 13-17 岁青少年的国家、地区、州和选定局部地区疫苗接种覆盖率。
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116. doi: 10.15585/mmwr.mm6933a1.
3
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.全国、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2020 年。
MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1183-1190. doi: 10.15585/mmwr.mm7035a1.
4
Adolescent Vaccination Performance in South Carolina Compared to the United States.南卡罗来纳州与美国青少年疫苗接种情况对比
J S C Med Assoc. 2015;111(4):117-21.
5
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.国家、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2017 年。
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):909-917. doi: 10.15585/mmwr.mm6733a1.
6
The association of initiating HPV vaccination at ages 9-10 years and up-to-date status among adolescents ages 13-17 years, 2016-2020.9-10 岁开始接种 HPV 疫苗与 13-17 岁青少年 HPV 疫苗接种及时率的相关性。2016-2020 年。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2175555. doi: 10.1080/21645515.2023.2175555. Epub 2023 Feb 7.
7
Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.美国4个不同的医疗服务欠缺地区19至35个月大儿童的免疫接种覆盖率水平。
Pediatrics. 2004 Apr;113(4):e296-302. doi: 10.1542/peds.113.4.e296.
8
Up-to-date coverage with meningococcal vaccine among adolescents age 17 years: Patterns and correlates in the United States, 2017.17 岁青少年中脑膜炎球菌疫苗的最新接种情况:2017 年美国的模式和相关性。
Vaccine. 2019 Sep 20;37(40):5934-5938. doi: 10.1016/j.vaccine.2019.08.015. Epub 2019 Aug 28.
9
Parent-reported provider recommendation of HPV vaccination among minority adolescents before and during the COVID-19 pandemic: Findings from the National Immunization Survey-Teen, 2019-2021.家长报告的新冠疫情之前及期间少数族裔青少年人乳头瘤病毒(HPV)疫苗接种的医疗服务提供者建议:2019 - 2021年全国青少年免疫调查结果
Prev Med Rep. 2023 Oct;35:102286. doi: 10.1016/j.pmedr.2023.102286. Epub 2023 Jun 21.
10
Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.国家免疫咨询委员会关于人乳头瘤病毒(HPV)疫苗的最新建议摘要:HPV免疫接种程序中九价人乳头瘤病毒(HPV)各剂次之间的最短间隔时间。
Can Commun Dis Rep. 2016 Jul 7;42(7):149-151. doi: 10.14745/ccdr.v42i07a03.

引用本文的文献

1
Components of a Digital Storytelling Intervention for Human Papillomavirus and Cancer Prevention Among LGBTQ+ Individuals: Formative Mixed Methods Inquiry.针对 LGBTQ+ 群体中人类乳头瘤病毒与癌症预防的数字叙事干预组件:形成性混合方法探究
JMIR Form Res. 2025 May 30;9:e58163. doi: 10.2196/58163.
2
Demographic disparities, temporal trends, and geographic patterns of HPV vaccination on Long Island, New York: A comprehensive analysis of immunization registry data (2012-2023).纽约长岛人乳头瘤病毒疫苗接种的人口统计学差异、时间趋势和地理模式:免疫登记数据的综合分析(2012 - 2023年)
Hum Vaccin Immunother. 2025 Dec;21(1):2487383. doi: 10.1080/21645515.2025.2487383. Epub 2025 Apr 15.
3
Obscured inequity: How focusing on rates of disparities can conceal inequities in the reasons why adolescents are unvaccinated.被掩盖的不平等:关注差异率如何掩盖了青少年未接种疫苗的原因中的不平等。
PLoS One. 2023 Nov 28;18(11):e0293928. doi: 10.1371/journal.pone.0293928. eCollection 2023.
4
Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities.医疗保健机构提供 HPV 疫苗接种服务的障碍和决定因素。
Hum Vaccin Immunother. 2023 Aug;19(2):2264596. doi: 10.1080/21645515.2023.2264596. Epub 2023 Oct 17.
5
Barriers to human papillomavirus vaccine uptake: role of state religiosity and healthcare professionals' participation in a state vaccine program.人乳头瘤病毒疫苗接种的障碍:国家宗教信仰和医疗保健专业人员参与国家疫苗计划的作用。
JNCI Cancer Spectr. 2023 Aug 31;7(5). doi: 10.1093/jncics/pkad068.
6
Parent-reported provider recommendation of HPV vaccination among minority adolescents before and during the COVID-19 pandemic: Findings from the National Immunization Survey-Teen, 2019-2021.家长报告的新冠疫情之前及期间少数族裔青少年人乳头瘤病毒(HPV)疫苗接种的医疗服务提供者建议:2019 - 2021年全国青少年免疫调查结果
Prev Med Rep. 2023 Oct;35:102286. doi: 10.1016/j.pmedr.2023.102286. Epub 2023 Jun 21.
7
Human Papillomavirus Vaccination Uptake in the Rio Grande Valley: Results from a Pilot Community-Based Educational and School-Based Vaccination Program and Its Expansion.里奥格兰德河谷地区人乳头瘤病毒疫苗接种情况:一项基于社区的教育及基于学校的疫苗接种试点项目及其扩展的结果
Vaccines (Basel). 2023 Feb 1;11(2):329. doi: 10.3390/vaccines11020329.
8
Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination.医务人员 HPV 疫苗接种培训与 HPV 疫苗接种状况评估和 HPV 疫苗接种推荐相关。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2132755. doi: 10.1080/21645515.2022.2132755. Epub 2022 Oct 20.
9
Human papillomavirus vaccinations at recommended ages: How a middle school-based educational and vaccination program increased uptake in the Rio Grande Valley.推荐年龄的人乳头瘤病毒疫苗接种:基于中学的教育和疫苗接种计划如何提高里奥格兰德河谷的接种率。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2133315. doi: 10.1080/21645515.2022.2133315. Epub 2022 Oct 17.

本文引用的文献

1
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.全国、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2020 年。
MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1183-1190. doi: 10.15585/mmwr.mm7035a1.
2
Factors Associated With Human Papillomavirus Vaccine Series Completion Among Adolescents.青少年人乳头瘤病毒疫苗系列接种完成情况相关因素分析。
Am J Prev Med. 2021 Nov;61(5):701-708. doi: 10.1016/j.amepre.2021.04.031. Epub 2021 Jul 10.
3
Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge.HPV 疫苗接种后的长期免疫原性综述:当前知识的空白。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1908059. doi: 10.1080/21645515.2021.1908059. Epub 2021 May 25.
4
Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?谈论推荐年龄或更少剂量:是什么促使 HPV 疫苗接种及时进行?
Hum Vaccin Immunother. 2021 Sep 2;17(9):3077-3080. doi: 10.1080/21645515.2021.1912550. Epub 2021 May 7.
5
Stakeholders' perspectives on system-level barriers to and facilitators of HPV vaccination among Hispanic migrant farmworkers.利益相关者对西班牙裔移民农场工人 HPV 疫苗接种的系统障碍和促进因素的看法。
Ethn Health. 2022 Aug;27(6):1442-1464. doi: 10.1080/13557858.2021.1887820. Epub 2021 Mar 18.
6
The association between state Medicaid expansion and human papillomavirus vaccination.州医疗补助计划扩张与人类乳头瘤病毒疫苗接种之间的关联。
Vaccine. 2020 Aug 27;38(38):5963-5965. doi: 10.1016/j.vaccine.2020.07.024. Epub 2020 Jul 22.
7
The nonavalent vaccine: a review of high-risk HPVs and a plea to the CDC.九价疫苗:高危型人乳头瘤病毒综述及向美国疾病控制与预防中心的呼吁。
Am J Stem Cells. 2019 Dec 15;8(3):52-64. eCollection 2019.
8
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.不同人乳头瘤病毒(HPV)疫苗类型及接种程序对预防女性和男性HPV相关疾病的比较。
Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD013479. doi: 10.1002/14651858.CD013479.
9
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018.全国、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2018 年。
MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723. doi: 10.15585/mmwr.mm6833a2.
10
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.人乳头瘤病毒疫苗接种:免疫实践咨询委员会的最新建议。
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3.